American Journal of Medicine and Medical Sciences
p-ISSN: 2165-901X e-ISSN: 2165-9036
2025; 15(5): 1515-1518
doi:10.5923/j.ajmms.20251505.46
Received: Apr. 25, 2025; Accepted: May 23, 2025; Published: May 27, 2025
Abdullaev Zh. U., Mirakhmedova Kh. T., Saidrasulova G. B.
Tashkent Medical Academy, Tashkent, Uzbekistan
Copyright © 2025 The Author(s). Published by Scientific & Academic Publishing.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
To evaluate clinical differences between reactive arthritis associated with COVID-19 and urogenital etiology. Materials and methods. The study included 195 patients. The first group consisted of 135 patients who had suffered COVID-19, the second group consisted of 60 patients with reactive arthritis of urogenital etiology. General clinical, laboratory and instrumental studies of patients were assessed. Results. It was found that the average age of patients in the first group is 1.45 times greater than in the second. In the study participated more women than men: in the first group there were 1.8 times more women than men. In contrast, in the second group there were 1.4 times more men than women. In the first group, the disease manifests predominantly in a polyarticular form, and in the second group - in a mono- or oligo-articular form. Conclusion. Reactive arthritis associated with COVID-19 occurs primarily in older adults, is relatively more common in women, and tends to be poly-articular form.
Keywords: COVID-19, Reactive arthritis, COVID-19 associated reactive arthritis, Urogenital etiology, Monoarthritis, Oligoarthritis, Polyarthritis, SARS-CoV-2 IgG
Cite this paper: Abdullaev Zh. U., Mirakhmedova Kh. T., Saidrasulova G. B., Clinical Differentiation Between COVID-19-associated Reactive Arthritis and Urogenital Etiology Classic Reactive Arthritis, American Journal of Medicine and Medical Sciences, Vol. 15 No. 5, 2025, pp. 1515-1518. doi: 10.5923/j.ajmms.20251505.46.
![]() | Figure 1. Average age of patients participating in the study, years |
![]() | Figure 2. Gender ratio of patients participating in the study |
![]() | Figure 3. Severity of COVID-19 by patient |
![]() | Figure 4. Patterns of progression of reactive arthritis in patients |
|